<DOC>
	<DOCNO>NCT02746133</DOCNO>
	<brief_summary>The purpose study characterise patient disease profile influence protein-restricted diet supplement keto acids/amino acid ( KA/AA ) , focus progression chronic renal insufficiency , calcium phosphorus metabolism , nutritional status , patient compliance diet Ketosteril intake well persistent dietary education ensure compliance large group pre-dialysis patient .</brief_summary>
	<brief_title>Observational Study CKD Treatment With Ketosteril Supplemented Protein-restricted Diet ( Keto-027-CNI )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>write informed consent nondialyzed patient CKD indication Ketosteril accord Summary Product Characteristics ( SmPC ) , include glomerular filtration rate ( GFR ) &lt; 25 mL/min accept supplement proteinrestricted diet newly start Ketosteril ( treatment naïve , i.e. , never treat Ketosteril ) adult patient ≥ 18 year active cancer diseases pregnancy breast feed hypersensitivity active substance excipients Ketosteril hypercalcaemia major disorder amino acid metabolism , e.g. , hereditary disease participation clinical trial investigational drug within 30 day prior start study study illiteracy incapability read write</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>